Detalhe da pesquisa
1.
A metabolic function of FGFR3-TACC3 gene fusions in cancer.
Nature
; 553(7687): 222-227, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29323298
2.
Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas.
Proc Natl Acad Sci U S A
; 114(25): 6581-6586, 2017 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28607076
3.
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
Clin Cancer Res
; 26(3): 690-703, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636099
4.
Mass spectrometry and proteomics in hematology.
Semin Hematol
; 56(1): 52-57, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573045
5.
A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment.
Oncotarget
; 8(69): 113895-113909, 2017 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371955
6.
High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.
Cancer Res
; 75(13): 2600-2606, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25931286
7.
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.
Nat Commun
; 6: 8470, 2015 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26415585
8.
SIGNALING PATHWAYS AS BIOMARKERS.
Biomark Cancer
; 7(Suppl 2): 33-5, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26917979